Impact of Combined Vascular Resection and Reconstruction in Patients with Advanced Perihilar Cholangiocarcinoma

被引:8
作者
Kuriyama, Naohisa [1 ]
Komatsubara, Haruna [1 ]
Nakagawa, Yuki [1 ]
Maeda, Koki [1 ]
Shinkai, Toru [1 ]
Noguchi, Daisuke [1 ]
Ito, Takahiro [1 ]
Gyoten, Kazuyuki [1 ]
Hayasaki, Aoi [1 ]
Fujii, Takehiro [1 ]
Iizawa, Yusuke [1 ]
Murata, Yasuhiro [1 ]
Tanemura, Akihiro [1 ]
Kishiwada, Masashi [1 ]
Sakurai, Hiroyuki [1 ]
Mizuno, Shugo [1 ]
机构
[1] Mie Univ, Grad Sch Med, Dept Hepatobiliary Pancreat & Transplant Surg, 2-174 Edobashi, Tsu, Mie 5148507, Japan
关键词
Perihilar cholangiocarcinoma; Vascular resection and reconstruction; Carcinoembryonic antigen;
D O I
10.1007/s11605-021-05004-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Perihilar cholangiocarcinoma often involves the adjacent vasculature, including the portal vein and hepatic artery. Combined vascular resection and reconstruction of the portal vein is more common than vascular resection and reconstruction of the hepatic artery. Herein, we aimed to elucidate the long-term outcomes in patients who underwent vascular resection and reconstruction for perihilar cholangiocarcinoma. Methods Between January 2004 and December 2020, 106 patients with perihilar cholangiocarcinoma were grouped into the no resection (n = 58), resection-portal vein (n = 31), and resection-hepatic artery with or without that of portal vein (n = 17) groups. Results There were no significant differences in morbidity and mortality between the three groups. The resection-portal vein and resection-hepatic artery groups had a significantly higher number of advanced tumors than the no resection group, but no significant differences were detected in the rates of lymph node metastasis and R0 resection between the three groups. The 5-year disease-specific survival in the resection-portal vein (37.6%) and resection-hepatic artery (26.9%) groups were poorer than that in the no resection group (47.8%), although the former groups had a significantly better prognosis than the latter group (7.0%). Multivariate analysis identified high preoperative carcinoembryonic antigen level (>5.7 ng/mL), intrahepatic metastasis, and non-R0 resection as independent poor prognostic factors. Conclusion Although the perioperative course in the resection-portal vein and hepatic artery groups was similar to that in the no resection group, the long-term prognoses were poor in the resection-portal vein and hepatic artery groups. Pre- and postoperative multidisciplinary therapy is required for patients with vascular resection and reconstruction.
引用
收藏
页码:3108 / 3118
页数:11
相关论文
共 26 条
  • [1] Systematic review and meta-analysis of the role of vascular resection in the treatment of hilar cholangiocarcinoma
    Abbas, Saleh
    Sandroussi, Charbel
    [J]. HPB, 2013, 15 (07) : 492 - 503
  • [2] Bai T, 2015, INT J CLIN EXP MED, V8, P21044
  • [3] Combined portal vein resection in the treatment of hilar cholangiocarcinoma: A systematic review and meta-analysis
    Chen, W.
    Ke, K.
    Chen, Y. L.
    [J]. EJSO, 2014, 40 (05): : 489 - 495
  • [4] The Clavien-Dindo Classification of Surgical Complications Five-Year Experience
    Clavien, Pierre A.
    Barkun, Jeffrey
    de Oliveira, Michelle L.
    Vauthey, Jean Nicolas
    Dindo, Daniel
    Schulick, Richard D.
    de Santibanes, Eduardo
    Pekolj, Juan
    Slankamenac, Ksenija
    Bassi, Claudio
    Graf, Rolf
    Vonlanthen, Rene
    Padbury, Robert
    Cameron, John L.
    Makuuchi, Masatoshi
    [J]. ANNALS OF SURGERY, 2009, 250 (02) : 187 - 196
  • [5] Surgical Outcomes for Perihilar Cholangiocarcinoma with Vascular Invasion
    Higuchi, Ryota
    Yazawa, Takehisa
    Uemura, Shuichiro
    Izumo, Wataru
    Ota, Takehiro
    Kiyohara, Kosuke
    Furukawa, Toru
    Egawa, Hiroto
    Yamamoto, Masakazu
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2019, 23 (07) : 1443 - 1453
  • [6] Hepatic Artery Resection for Bismuth Type III and IV Hilar Cholangiocarcinoma: Is Reconstruction Always Required?
    Hu, Hai-Jie
    Jin, Yan-Wen
    Zhou, Rong-Xing
    Shrestha, Anuj
    Ma, Wen-Jie
    Yang, Qin
    Wang, Jun-Ke
    Liu, Fei
    Cheng, Nan-Sheng
    Li, Fu-Yu
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2018, 22 (07) : 1204 - 1212
  • [7] Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China
    Hu, Hai-Jie
    Mao, Hui
    Shrestha, Anuj
    Tan, Yong-Qiong
    Ma, Wen-Jie
    Yang, Qin
    Wang, Jun-Ke
    Cheng, Nan-Sheng
    Li, Fu-Yu
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (08) : 2601 - 2610
  • [8] Surgical approach to bismuth type I and II hilar cholangiocarcinomas
    Ikeyama, Takashi
    Nagino, Masato
    Oda, Koji
    Ebata, Tomoki
    Nishio, Hideki
    Nimura, Yuji
    [J]. ANNALS OF SURGERY, 2007, 246 (06) : 1052 - 1057
  • [9] High tumor budding is a strong predictor of poor prognosis in the resected perihilar cholangiocarcinoma patients regardless of neoadjuvant therapy, showing survival similar to those without resection
    Ito, Takahiro
    Kuriyama, Naohisa
    Kozuka, Yuji
    Komatsubara, Haruna
    Ichikawa, Ken
    Noguchi, Daisuke
    Hayasaki, Aoi
    Fujii, Tekehiro
    Iizawa, Yusuke
    Kato, Hiroyuki
    Tanemura, Akihiro
    Murata, Yasuhiro
    Kishiwada, Masashi
    Mizuno, Shugo
    Usui, Masanobu
    Sakurai, Hiroyuki
    Isaji, Shuji
    [J]. BMC CANCER, 2020, 20 (01)
  • [10] Kawarada Y, 2000, J Hepatobiliary Pancreat Surg, V7, P580, DOI 10.1007/s005340070007